Patents by Inventor Ernest C. Adams

Ernest C. Adams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5166051
    Abstract: A diagnostic test strip for chemically determining whole blood analytes comprises a support, a porous detection zone membrane affixed to the support, and an overlay membrane affixed to the support and in overlying and continuous contact with the detection zone membrane. The overlay membrane has a crenating agent for the exclusion of whole red blood cells from the pores of the detection zone membrane.
    Type: Grant
    Filed: August 8, 1990
    Date of Patent: November 24, 1992
    Assignee: Genesis Labs, Inc.
    Inventors: Yvonne M. Killeen, Ernest C. Adams, Karen R. Mason
  • Patent number: 5130231
    Abstract: Single or multiple blood plasma component concentrations are measured by a disposable stick having one or more blood plasma component reactive areas covered by a semipermeable membrane which is permeable by blood plasma or serum components and impermeable by blood cellular and particulate matter. A second overlay may be superposed with the semipermeable membrane over the reactive areas to receive a blood sample and meter and distribute that sample uniformly to the semipermeable membrane which in turn passes the plasma components uniformly to the reactive areas. The overlays are subsequently separable from the reactive area to remove the cellular components and particulate matter and expose the reactive areas for inspection by, for example, color comparison to standardized charts.
    Type: Grant
    Filed: June 12, 1989
    Date of Patent: July 14, 1992
    Assignee: Chem-Elec, Inc.
    Inventors: Paul R. Kennedy, Ernest C. Adams, William E. Woenke
  • Patent number: 4839296
    Abstract: Single or multiple blood plasma component concentrations are measured by a disposable stick having one or more blood plasma component reactive areas covered by a semipermeable membrane which is permeable by blood plasma or serum components and inpermeable by blood cellular and particulate matter. A second overlap may be superposed with the semipermeable membrane over the reactive areas to receive a blood sample and meter and distribute that sample uniformly to the semipermeable membrane which in turn passes the plasma components uniformly to the reactive areas. The overlays are subsequently separable from the reactive area to remove the cellular components and particulate matter and expose the reactive areas for inspection by, for example, color comparison to standardized charts.
    Type: Grant
    Filed: October 18, 1985
    Date of Patent: June 13, 1989
    Assignee: Chem-Elec, Inc.
    Inventors: Paul R. Kennedy, Ernest C. Adams, William E. Woenker
  • Patent number: 4786596
    Abstract: Ethyl alcohol test strip fabricating and use techniques for testing an individual's saliva to determine his sobriety are disclosed. The test strips employ an alcohol oxidase, Peroxidase and an hydrogen donor indicator such as Tetraalkylbenzidine in a carrier matrix supported on the strip with the alcohol oxidase functioning as a catalyst to convert any ethanol present along with ambient oxygen to acetaldehyde and hydrogen peroxide. The peroxidase function as catalyst to induce a color change in the hydrogen donor and convert the hydrogen peroxide to water. The method of fabricating the test strip involves multiple steps of reagent application and hot air drying.
    Type: Grant
    Filed: February 20, 1985
    Date of Patent: November 22, 1988
    Assignee: Chem-Elec., Inc.
    Inventor: Ernest C. Adams
  • Patent number: 4542103
    Abstract: A method for determining the amount of IgG present in a neonatal foal or calf or in the colostrum of a dam or cow. The method involves contacting a body fluid sample with biologically inert latex particles, measuring the amount of agglutination which occurs, and determining the amount of IgG present. The latex particles are diluted to a final concentration of from about 0.25 to 2.0 percent (w/v) at a pH of from about 7.5 to 9.0 with a buffer. The body fluid is diluted to a range of from 0.01:5 parts to 0.01:2160 parts, v/v basis, at a pH of from about 7.5 to 9.0.
    Type: Grant
    Filed: November 16, 1983
    Date of Patent: September 17, 1985
    Assignee: Miles Laboratories Inc.
    Inventor: Ernest C. Adams
  • Patent number: 4189304
    Abstract: A test device and method for detecting myoglobin in the presence of hemoglobin in a fluid test sample. The test device comprises a chromatographic medium incorporating serum, haptoglobin and/or antiserum which binds or retards hemoglobin while permitting myoglobin to traverse the length of the test device. A test sample of body fluid is placed in contact with an appropriate portion of the chromatographic medium of said test device; hemoglobin in the body fluid is retained or retarded by the serum, haptoglobin and/or antiserum; and myoglobin in the sample traverses the length of the medium and contacts reagent means at a predetermined location thereon, resulting in a detectable response thereat.
    Type: Grant
    Filed: October 27, 1978
    Date of Patent: February 19, 1980
    Assignee: Miles Laboratories, Inc.
    Inventors: Ernest C. Adams, Jr., Kathleen M. Layman